OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Microbiology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	145
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	75
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	66
TREM-2: friend or foe in infectious diseases?	65
EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential	56
Salmonella in eggs and egg-laying chickens: pathways to effective control	52
Helicobacter pylori infection: from standard to alternative treatment strategies	42
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	40
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	37
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	36
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	36
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	33
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	32
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	32
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects	30
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	29
LysR-type transcriptional regulators: state of the art	27
Applications of bacteriophages against intracellular bacteria	27
Exploring halophilic environments as a source of new antibiotics	27
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	26
Vibrio cholerae virulence and its suppression through the quorum-sensing system	26
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	25
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge	25
Emerging cellular and molecular interactions between the lung microbiota and lung diseases	24

The microbiome and precision oncology: an emerging paradigm in anticancer therapy	24
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	24